Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Nuvation Bio

Biotech & Life Sciences · New York City, United States · Founded 2018 · IPO 2020 Colt

Nuvation Bio is a biopharmaceutical company

Valuation
$1.08B
Market cap · May/2026
Revenue
$63M
Latest reported FY

Investors

4 investors on Nuvation Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage
Aisling Capital
EDBI
Omega Funds
Altitude Life Science Ventures

Global footprint

Where Nuvation Bio has talent and traffic

AI talent share
0.9% of workforce is AI talent
(2 of 234 staff)
Core AI00%
Other AI20.85%
Non-AI workforce23299.15%
Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown
Web traffic by country
20K monthly visits
across markets
🇺🇸 United States92.5%
🇨🇦 Canada5.5%
🇮🇳 India0.5%
Top 3 markets shown

Market sentiment

What the market is saying about Nuvation Bio

An AI-synthesized read of the highest-engagement posts about Nuvation Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nuvation Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.